Clinical Trials on No Condition. Assessment of Healthy Volunteers. in New Zealand

Total 114 results

Presidio Pharmaceuticals, Inc.

Completed

Phase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations

Pharmacokinetic Assessments in Healthy Volunteers

United States
Presidio Pharmaceuticals, Inc.

Completed

Phase 1 Study of Relative Bioavailability of PPI-668 Tablet and Capsule Formulations

Pharmacokinetic Assessments in Healthy Volunteers

United States
National Cancer Institute (NCI)

Completed

Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients

Healthy, no Evidence of Disease

United States
Regeneron Pharmaceuticals

Active, not recruiting

A Trial to Learn if Different Doses of REGN7544 Are Safe in Healthy Adult Participants

Healthy Volunteers

New Zealand
University of Sydney

Completed

Composition of Functional Tooth Units and Nutrient Intake in Older Men (CHAMP)

Oral Health of Older Men | Dietary Assessment of Older Men

Australia
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Terminated

Cholecalciferol and Flu Vaccine in Treating Healthy Participants

Healthy, no Evidence of Disease

United States
Astellas Pharma Global Development, Inc.
Yale University

Completed

A Positron Emission Tomography Occupancy Study Using Ligand [11C]AS2471907 and Following Oral Dosing of ASP3662

Healthy Volunteers | Pharmacokinetics of ASP3662 | Displacement of Radiotracer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Collection of Bone Marrow From Donors Treated With or Without Filgrastim

No Evidence of Disease | Healthy Stem Cell Donor

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI); Fred Hutchinson Cancer Center; University of... and other collaborators

Completed

Biomarkers in Post-Menopausal Women Receiving Flaxseed

No Evidence of Disease

United States
Zenas BioPharma (USA), LLC

Active, not recruiting

A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthritis

Rheumatoid Arthritis | Healthy Volunteers

New Zealand, Australia
Hoffmann-La Roche

Completed

A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1

Hepatitis C, Chronic, Healthy Volunteer

New Zealand
Roswell Park Cancer Institute

Completed

Narrative or Fact-Based Videos in Increasing Colorectal Cancer Screenings in African American Communities

Colorectal Cancer | Healthy, no Evidence of Disease

United States
National Cancer Institute (NCI)

Completed

Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers

No Evidence of Disease

United States
National Cancer Institute (NCI)

Completed

Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers

No Evidence of Disease

United States
Takeda

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics (PK) of Oral TAK-994 in an Acute Sleep Phase Delay Paradigm in Healthy Male Participants

Healthy Volunteers

United States
Pfizer

Completed

A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers

Healthy Volunteers

United States
Pfizer

Completed

Bioavailability Study of Naloxone 5 Milligrams (mg) Intramuscular (IM) Autoinjector

Healthy Volunteers

United States
Allergan

Completed

Tear Collection in Adult Volunteers

Healthy Volunteers

Australia
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

Evaluation of Changes to Skin Microbiome With Tape-Stripped Wounds

Healthy Volunteers

United States
Rockefeller University

Terminated

Effect of Metabolic State on Anxiety in Human Subjects

Healthy Volunteers

United States
Northwell Health

Completed

Using a Transcutaneous Electrical Auricular Stimulator to Harness the Cholinergic Anti-Inflammatory Pathway (TEACAP)

Healthy Volunteers

United States
Pfizer
ViiV Healthcare

Completed

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects

Healthy Volunteers

United States
Pfizer

Completed

Bioequivalence Study Of Verapamil

Healthy Volunteers

United States
Allergan

Completed

Perception of Facial Expression in Subjects With and Without Crow's Feet Lines

Healthy Volunteers

United States
NYU Langone Health

Completed

Evaluation of Salt Sensitivity in Young Adults

Healthy Volunteers

United States
Hoffmann-La Roche

Completed

A Pharmacokinetic Study of RO4917523 in Healthy Japanese and Caucasian Subjects

Healthy Volunteer

United States
Topcon Medical Systems, Inc.

Completed

Clinical Study of the Optic Disc Parameters

Normal Healthy Subjects With No Known Ocular Diseases | Glaucomatous Eyes | Eyes With Retinal Diseases

United States
UCB Pharma

Completed

Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body

Healthy Volunteers

Germany
Pfizer
ViiV Healthcare

Completed

Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects

Healthy Volunteers

United States, Belgium
UCB Pharma

Completed

Study in Healthy Volunteers to Prove That Two Rotigotine Patches From Different Manufacturing Sites Deliver Equivalent Drug Amount to the Body

Healthy Volunteers

Germany
Biogen

Completed

Study to Investigate the Effect of GSK1014802 on Ambulatory Blood Pressure

Healthy Volunteer

United States
Hoffmann-La Roche

Completed

A Study of Three Modified-Release Formulations of RO4917523 in Healthy Volunteers

Healthy Volunteer

United States
Almirall, S.A.
Allergan

Completed

Phototoxicity Test of Dapsone Gel in Healthy Volunteers

Healthy Volunteers

United States
Invicro

Completed

Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444

Healthy Volunteer

United States
Ochsner Health System

Unknown

Quantification of Myocardial Blood Flow by Positron Emission Tomography in Healthy Volunteers (PET Normals)

Normal Healthy Volunteers Without Chronic Medical Conditions

United States
Takeda

Completed

Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults

Healthy Volunteers | Norovirus

Belgium, United States
AstraZeneca

Completed

Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers

Healthy Volunteers

United States
Bayer

Not yet recruiting

A Study to Learn About Whether BAY H006689 Causes an Allergic Reaction When Applied as a Topical Gel in Healthy Participants

Pain | Healthy Volunteers

United States
Janssen Research & Development, LLC

Completed

Multiple Dose Pharmacokinetics of Canagliflozin/Metformin 150/1,000 mg Fixed Dose Combination

Healthy Volunteers

United States
Winston Laboratories

Completed

Civamide Patch Safety, Tolerability and PK Study

Healthy Volunteers

United States
Mannkind Corporation

Completed

Compare the Same Dosage of Insulin Using a Combination of Cartridges, 30 Units as 2 Cartridges vs. 1 Cartridge

Healthy Volunteers

United States
Mannkind Corporation

Completed

Pharmacokinetic Study in Healthy Volunteers

Healthy Volunteers

United States
Pfizer

Completed

CP-690,550 and Midazolam Drug-Drug Interaction Study

Healthy Volunteer

United States
Amgen

Terminated

Study to Evaluate the Safety and Tolerability of AMG 986 in Healthy Volunteers and Heart Failure Patients

Heart Failure | Healthy Volunteer

France, United States, Netherlands, New Zealand, Germany, Australia, Poland, Canada, Singapore
Pyramid Biosciences

Completed

A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical Cream

Psoriasis | Healthy Volunteers

United States
Kadmon, a Sanofi Company

Completed

A Study to Determine the Effect of 500 mg Oral Dose of KD025 in Healthy Male and Post-menopausal Female Subjects

Immune System Disorder (Healthy Volunteer)

United States
Kadmon, a Sanofi Company

Completed

A Study to Determine the Effect of Multiple Oral Doses and Regimens of KD025 in Healthy Male and Post-menopausal Female Subjects

Immune System Disorder (Healthy Volunteer)

United States
National Cancer Institute (NCI)

Completed

Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants

Prostate Carcinoma | No Evidence of Disease

United States
Pharmasset
Hoffmann-La Roche

Completed

Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin (R7128)

Healthy Volunteers | Hepatitis C Virus

United States, Puerto Rico, New Zealand
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Completed

Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma

Melanoma | Health Status Unknown | Dysplastic Nevus | No Evidence of Disease

United States

Clinical Trials on No Condition. Assessment of Healthy Volunteers. in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations